ACHILLES THERAPEUTICS PL-ADR (ACHL)

US00449L1026 - ADR

0.9478  +0.03 (+3.57%)

Premarket: 0.912 -0.04 (-3.78%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
71.00M75.25M77.88M64.20M33.73M
Research and Development
54.51M58.25M56.76M42.22M22.63M
Selling, General, and Administrative Expenses
16.48M17.01M21.12M21.97M11.10M
Operating Income
-71.00M-75.25M-77.88M-64.20M-33.73M
Interest Income/Expense
400.00K-1.00M3.80M2.50M100.00K
Other Income/Expense
6.59M7.08M3.52M630.00K430.00K
Non Recurring Items
N/AN/A-500.00KN/AN/A
Income Before Taxes
-64.01M-69.17M-71.07M-61.06M-33.20M
Income Tax
428.00K491.00K110.00K40.00K0.00
Net Income
-64.44M-69.67M-71.18M-61.10M-33.20M
EBITDA
-66.22M-70.54M-74.19M-60.91M-32.96M
 
Per Share Data
EPS Diluted Total Ops
-1.56-1.69-1.77-2.07-0.80
Non GAAP EPS
-1.60-1.74-1.82-9.62N/A
 
Statistics

All data in USD

Charts